These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28376187)

  • 1. A Novel Diagnostic Tool for Selecting Patients With Mesenchymal-Type Colon Cancer Reveals Intratumor Subtype Heterogeneity.
    Ubink I; Elias SG; Moelans CB; Laclé MM; van Grevenstein WMU; van Diest PJ; Borel Rinkes IHM; Kranenburg O
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT).
    Ubink I; Bloemendal HJ; Elias SG; Brink MA; Schwartz MP; Holierhoek YCW; Verheijen PM; Boerman AW; Mathijssen RHJ; de Leng WWJ; de Weger RA; van Grevenstein WMU; Koopman M; Lolkema MP; Kranenburg O; Borel Rinkes IHM
    BMC Cancer; 2017 Apr; 17(1):282. PubMed ID: 28424071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.
    Peters NA; Constantinides A; Ubink I; van Kuik J; Bloemendal HJ; van Dodewaard JM; Brink MA; Schwartz TP; Lolkema MPJK; Lacle MM; Moons LM; Geesing J; van Grevenstein WMU; Roodhart JML; Koopman M; Elias SG; Borel Rinkes IHM; Kranenburg O
    Front Oncol; 2022; 12():969855. PubMed ID: 36147916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.
    Tamborini E; Miselli F; Negri T; Lagonigro MS; Staurengo S; Dagrada GP; Stacchiotti S; Pastore E; Gronchi A; Perrone F; Carbone A; Pierotti MA; Casali PG; Pilotti S
    Clin Cancer Res; 2006 Dec; 12(23):6920-8. PubMed ID: 17145809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine.
    Mouillet-Richard S; Cazelles A; Sroussi M; Gallois C; Taieb J; Laurent-Puig P
    Clin Cancer Res; 2024 Jun; 30(11):2351-2358. PubMed ID: 38564259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.
    Haberler C; Gelpi E; Marosi C; Rössler K; Birner P; Budka H; Hainfellner JA
    J Neurooncol; 2006 Jan; 76(2):105-9. PubMed ID: 16205964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
    Raafat A; Zoltan-Jones A; Strizzi L; Bargo S; Kimura K; Salomon D; Callahan R
    Oncogene; 2007 Feb; 26(5):662-72. PubMed ID: 16878155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S; Brama M; Mariani S; De Luca G; Arizzi M; Vesci L; Pisano C; Dolci S; Spera G; Gnessi L
    Cancer Res; 2005 Mar; 65(5):1897-903. PubMed ID: 15753388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).
    Heinrich MC; McArthur GA; Demetri GD; Joensuu H; Bono P; Herrmann R; Hirte H; Cresta S; Koslin DB; Corless CL; Dirnhofer S; van Oosterom AT; Nikolova Z; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2006 Mar; 24(7):1195-203. PubMed ID: 16505440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA expression of platelet-derived growth factor receptor-beta and C-KIT: correlation with pathologic response to cetuximab-based chemoradiotherapy in patients with rectal cancer.
    Erben P; Horisberger K; Muessle B; Müller MC; Treschl A; Ernst T; Kähler G; Ströbel P; Wenz F; Kienle P; Post S; Hochhaus A; Willeke F; Hofheinz RD
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1544-50. PubMed ID: 19028276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
    Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
    Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.
    Schirosi L; Lantuejoul S; Cavazza A; Murer B; Yves Brichon P; Migaldi M; Sartori G; Sgambato A; Rossi G
    Am J Surg Pathol; 2008 Nov; 32(11):1627-42. PubMed ID: 18753943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
    Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
    Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorphism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation.
    Trojani A; Ripamonti CB; Penco S; Beghini A; Nadali G; Di Bona E; Viola A; Castagnola C; Colapietro P; Grillo G; Pezzetti L; Ravelli E; Patrosso MC; Marocchi A; Cuneo A; Ferrara F; Lazzarino M; Pizzolo G; Cairoli R; Morra E
    Anticancer Res; 2008; 28(5A):2745-51. PubMed ID: 19035305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interconnectivity between molecular subtypes and tumor stage in colorectal cancer.
    Coebergh van den Braak RRJ; Ten Hoorn S; Sieuwerts AM; Tuynman JB; Smid M; Wilting SM; Martens JWM; Punt CJA; Foekens JA; Medema JP; IJzermans JNM; Vermeulen L
    BMC Cancer; 2020 Sep; 20(1):850. PubMed ID: 32887573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
    Rocconi RP; Matthews KS; Kimball KJ; Conner MG; Baker AC; Barnes MN
    Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
    Di Narzo AF; Tejpar S; Rossi S; Yan P; Popovici V; Wirapati P; Budinska E; Xie T; Estrella H; Pavlicek A; Mao M; Martin E; Scott W; Bosman FT; Roth A; Delorenzi M
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25246611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.